Literature DB >> 25676521

Treatment of slowly growing mycobacteria.

Julie V Philley1, David E Griffith2.   

Abstract

The most common nontuberculous mycobacterial (NTM) lung pathogen, Mycobacterium avium complex (MAC), requires antibiotic treatment regimens that are long and often arduous. M kansasii is the slowly growing NTM pathogen with the most predictably successful treatment outcomes, whereas other slowly growing NTM pathogens such as M xeonpi, M szulgai, and M malmoense are less predictably responsive to antibiotic regimens. M simiae is the most difficult of the common slowly growing NTM pathogens to eradicate. Surgical intervention for slowly growing mycobacterial lung infection has proved beneficial for some patients, but the optimal candidates and timing for surgical intervention remain unknown.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bronchiectasis; M avium; MAC; Mycobacterial disease; Mycobacterium avium complex; NTM; Nontuberculous mycobacteria; Slow-growing mycobacteria

Mesh:

Substances:

Year:  2014        PMID: 25676521     DOI: 10.1016/j.ccm.2014.10.005

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  24 in total

1.  Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.

Authors:  Byung Woo Jhun; Seong Mi Moon; Su-Young Kim; Hye Yun Park; Kyeongman Jeon; O Jung Kwon; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Myung Jin Chung; Kyung Soo Lee; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

2.  Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.

Authors:  Byeong-Ho Jeong; Kyeongman Jeon; Hye Yun Park; Seong Mi Moon; Su-Young Kim; Soo-Youn Lee; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

3.  Treatment of Non-Tuberculous Mycobacterial Lung Disease.

Authors:  Julie V Philley; Mary Ann DeGroote; Jennifer R Honda; Michael M Chan; Shannon Kasperbauer; Nicholas D Walter; Edward D Chan
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-11

4.  Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.

Authors:  Seong Mi Moon; Hye Yun Park; Su-Young Kim; Byung Woo Jhun; Hyun Lee; Kyeongman Jeon; Dae Hun Kim; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Seung-Heon Lee; Chang Ki Kim; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

5.  Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.

Authors:  Sun Hye Shin; Byung Woo Jhun; Su-Young Kim; Junsu Choe; Kyeongman Jeon; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

6.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

7.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

8.  A case of pulmonary infection due to Mycobacterium paraffinicum from the Amazon Region.

Authors:  Adriana Rodrigues Barretto; José Tadeu Colares Monteiro; Maria Luiza Lopes; Ana Roberta Fusco da Costa
Journal:  IDCases       Date:  2017-07-12

Review 9.  Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.

Authors:  Yong-Soo Kwon; Won-Jung Koh
Journal:  J Korean Med Sci       Date:  2016-03-22       Impact factor: 2.153

Review 10.  Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives.

Authors:  Yon Ju Ryu; Won-Jung Koh; Charles L Daley
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.